In this study, two copies of APOL1 gene accounting for about 70% in FSGS patients and healthy controls, and the distribution of APOL1 CNV was not significantly different between FSGS patients and healthy controls. The gene discussed is APOL1; the disease is focal segmental glomerulosclerosis.